Automate Your Wheel Strategy on SMMT
With Tiblio's Option Bot, you can configure your own wheel strategy including SMMT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol SMMT
- Rev/Share 0.0
- Book/Share 0.4665
- PB 53.5878
- Debt/Equity 0.0187
- CurrentRatio 10.6302
- ROIC -0.4826
- MktCap 18566647500.0
- FreeCF/Share -0.2351
- PFCF -106.9848
- PE -76.6418
- Debt/Assets 0.0168
- DivYield 0
- ROE -0.705
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 3
- P/B Score 1
- D/E Score 4
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | SMMT | UBS | -- | Buy | -- | $30 | July 1, 2025 |
| Initiation | SMMT | Leerink Partners | -- | Underperform | -- | $12 | June 11, 2025 |
| Upgrade | SMMT | Citigroup | Neutral | Buy | $23 | $35 | March 26, 2025 |
| Initiation | SMMT | Cantor Fitzgerald | -- | Overweight | -- | -- | March 21, 2025 |
| Initiation | SMMT | Evercore ISI | -- | Outperform | -- | $30 | March 12, 2025 |
| Initiation | SMMT | Goldman | -- | Buy | -- | $42 | Feb. 28, 2025 |
| Initiation | SMMT | Truist | -- | Buy | -- | $35 | Jan. 8, 2025 |
| Initiation | SMMT | Wells Fargo | -- | Overweight | -- | $30 | Dec. 11, 2024 |
| Initiation | SMMT | Jefferies | -- | Buy | -- | $31 | Dec. 6, 2024 |
| Downgrade | SMMT | Citigroup | Buy | Neutral | $19 | $23 | Sept. 27, 2024 |
News
Pfizer: What The Summit Therapeutics Deal Brings
Published: February 24, 2025 by: Seeking Alpha
Sentiment: Neutral
Pfizer: What The Summit Therapeutics Deal Brings
Read More
3 Stocks That Could Trounce the Market in 2025
Published: February 17, 2025 by: The Motley Fool
Sentiment: Positive
If you're content with market-level returns, investing in an exchange-traded fund (ETF) is the way to go. But if not, you'll need to find stocks that hold the potential to pack more punch.
Read More
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: February 14, 2025 by: Business Wire
Sentiment: Neutral
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 116,725 shares of common stock. Awards were made to nine new employees of the Company. The awards were granted as an inducement material to the new employees becoming employees of the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and have been approved by the Company's Compensation Committ.
Read More
About Summit Therapeutics Inc. (SMMT)
- IPO Date 2015-03-05
- Website https://www.summittxinc.com
- Industry Biotechnology
- CEO Robert W. Duggan
- Employees 159